Nov 14 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2024 Sep 30, 2023 Dec 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 348 mln 313 mln 400 mln
(+11.1 pct) (+1.6 pct) (-6.6 pct)
Operating loss 647 mln loss 457 mln loss 1.50
Recurring loss 665 mln loss 453 mln loss 1.51
Net loss 727 mln loss 443 mln loss 1.51
EPS loss 21.61 yen loss 14.02 yen loss 47.00 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T